Gene polymorphisms of inflammatory factors in liver cirrhosis
暂无分享,去创建一个
S. Wen | Aizhong Liu | Xiongfeng Pan | Xun-Lan Huang | Yamin Liu | Sailan Xiao | S. Wen
[1] Chang Liu,et al. A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis , 2022, Journal of healthcare engineering.
[2] Hua Zeng,et al. IL-6 and IL-10 gene polymorphisms and cirrhosis of liver risk from a comprehensive analysis , 2021, BMC Endocrine Disorders.
[3] G. Temel,et al. Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients , 2021, Archives of virology.
[4] H. Nomeir,et al. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis , 2021, Asian Pacific journal of cancer prevention : APJCP.
[5] Pere Ginès,et al. Liver cirrhosis , 2021, The Lancet.
[6] J. Fallowfield,et al. Emerging synthetic drugs for the treatment of liver cirrhosis , 2021, Expert opinion on emerging drugs.
[7] Chuanmin Tao,et al. Relationships between IL-1β, TNF-α genetic polymorphisms and HBV infection: A meta-analytical study. , 2021, Gene.
[8] P. Muriel,et al. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver , 2020, Antioxidants.
[9] M. Sadeghi,et al. Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis , 2020, Clinical and experimental hepatology.
[10] A. Périanin,et al. The innate immune cells in cirrhosis. , 2020, Journal of hepatology.
[11] T. H. Nguyen,et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.
[12] M. Pinzani,et al. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. , 2019, Molecular aspects of medicine.
[13] P. Kamath,et al. Burden of liver diseases in the world. , 2019, Journal of hepatology.
[14] Chaolong Zhang,et al. Transforming growth factor-β1 gene polymorphisms with liver cirrhosis risk: A meta-analysis. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[15] Z. Dai,et al. IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study , 2017, Oncotarget.
[16] Z. Dai,et al. IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study , 2017, Oncotarget.
[17] C. Pairojkul,et al. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma , 2017, The Korean journal of parasitology.
[18] S. Friedman,et al. Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.
[19] A. Feldstein,et al. Inflammasomes in Liver Fibrosis , 2017, Seminars in Liver Disease.
[20] Y. Koyama,et al. Liver inflammation and fibrosis. , 2017, The Journal of clinical investigation.
[21] A. Medvedev,et al. Molecular mechanisms of regulation of Toll‐like receptor signaling , 2016, Journal of leukocyte biology.
[22] S. Dooley,et al. TGF‐β signalling and liver disease , 2016, The FEBS journal.
[23] W. Liu,et al. IL10 rs1800896 polymorphism is associated with liver cirrhosis and chronic hepatitis B. , 2016, Genetics and molecular research : GMR.
[24] Shan Li,et al. Role of IL-18 Gene Promoter Polymorphisms, Serum IL-18 Levels, and Risk of Hepatitis B Virus-related Liver Disease in the Guangxi Zhuang Population: a Retrospective Case-Control Study. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[25] Hongjie Song,et al. Association between interleukin-10 gene promoter polymorphisms and susceptibility to liver cirrhosis. , 2015, International journal of clinical and experimental pathology.
[26] Shan Li,et al. Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population , 2015, Cancer Cell International.
[27] Pengfei Guo,et al. Influence of IL10 gene polymorphisms on the severity of liver fibrosis and susceptibility to liver cirrhosis in HBV/HCV-infected patients. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[28] A. Zhang,et al. Interleukin-10 gene promoter polymorphism and risk of liver cirrhosis. , 2015, Genetics and molecular research : GMR.
[29] A. Fouad,et al. Role of transforming growth factor-β1 in serum and − 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients , 2014, Meta gene.
[30] Sun-Chong Wang,et al. Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients , 2014, The Kaohsiung journal of medical sciences.
[31] M. Radwan,et al. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. , 2012, Cytokine.
[32] Michael Karin,et al. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. , 2012, Gastroenterology.
[33] Y. Liu,et al. Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis. , 2011, Genetics and molecular research : GMR.
[34] M. Pirisi,et al. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. , 2011, Journal of hepatology.
[35] W. Jeong,et al. Suppression of innate immunity (natural killer cell/interferon‐γ) in the advanced stages of liver fibrosis in mice , 2011, Hepatology.
[36] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[37] L. Chouchane,et al. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. , 2009, Human immunology.
[38] C. Avellini,et al. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. , 2008, Cytokine.
[39] J. Armendáriz-Borunda,et al. Fibrogenic Polymorphisms (TGF-β, PAI-1, AT) in Mexican Patients With Established Liver Fibrosis. Potential Correlation With Pirfenidone Treatment , 2008, Journal of Investigative Medicine.
[40] L. Chouchane,et al. Association of interleukin‐18 polymorphisms and plasma level with the outcome of chronic HCV infection , 2008, Journal of medical virology.
[41] M. Raptopoulou-Gigi,et al. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease , 2007, Journal of viral hepatitis.
[42] R. González-Sarmiento,et al. -238 G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men. , 2005, Alcoholism, clinical and experimental research.
[43] M. Manns,et al. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C , 2003 .
[44] G. Davis,et al. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.
[45] S. Akira,et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. , 1998, Journal of immunology.
[46] Abeer Sheneef,et al. Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk. , 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[47] N. Méndez-Sánchez,et al. Management strategies for liver fibrosis. , 2017, Annals of hepatology.
[48] H. Shousha,et al. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[49] T. Meitinger,et al. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis? , 2009, Clinical chemistry and laboratory medicine.